iSERA Lifescienc

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: INE899M01020
  • NSEID:
  • BSEID: 534920
INR
143.90
0.00 (0.00%)
BSENSE

Nov 20

BSE+NSE Vol: 53

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 184341,
    "name": "iSERA Lifescienc",
    "stock_name": "iSERA Lifescienc",
    "full_name": "iSERA Lifesciences Ltd",
    "name_url": "stocks-analysis/isera-lifescienc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "143.90",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "143.90",
    "mcapval": "354.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 534920,
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE899M01020",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "53 ",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/isera-lifescienc-184341-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "iSERA Lifesciences Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/isera-lifesciences-ltd-is-rated-hold-4245492",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/iSERALifescienc_mojoScore_4245492.png",
        "date": "2026-10-31 10:10:03",
        "description": "iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 Sep 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "iSERA Lifesciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/isera-lifesciences-ltd-is-rated-hold-by-marketsmojo-4207203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/iSERALifescienc_mojoScore_4207203.png",
        "date": "2026-09-28 10:10:05",
        "description": "iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 September 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "iSERA Lifesciences Ltd’s Stagnant Week Masks 4.97% Surge and Valuation Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/isera-lifesciences-ltds-stagnant-week-masks-497-surge-and-valuation-concerns-4198879",
        "imagepath": "",
        "date": "2026-09-20 14:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Sep:</strong> Stock steady at Rs.143.90 despite Sensex decline</p>\n                    <p><strong>16 Sep:</strong> No price change, minimal volume</p>\n                    <p><strong>17 Sep:</strong> New 52-week high at Rs.151.05 (+4.97%)</p>\n                    <p><strong>18 Sep:</strong> Sharp correction to Rs.143.90 (-4.73%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.143.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.143.90</div><div class=\"stat-change\">+0.00%</div></..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts iSERA Lifesciences Ltd to 52-Week High of Rs 151.05",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/isera-lifesciences-ltd-hits-new-52-week-high-at-rs15105-4196513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/iSERALifescienc_priceRelatedfactors_4196513.png",
        "date": "2026-09-17 13:40:08",
        "description": "From a low of Rs 5.36 to a remarkable Rs 151.05, iSERA Lifesciences Ltd has surged over 2,600% in the past year, culminating in a fresh 52-week high on 17 Jun 2026. This extraordinary price momentum stands out sharply against the broader market backdrop, where the Sensex has declined by 10.12% over the same period."
      },
      {
        "title": "iSERA Lifesciences Ltd Valuation Shifts Signal Price Attractiveness Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/isera-lifesciences-ltd-valuation-shifts-signal-price-attractiveness-concerns-4195456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/iSERALifescienc_valuationdot_4195456.png",
        "date": "2026-09-17 08:00:13",
        "description": "iSERA Lifesciences Ltd has witnessed a dramatic shift in its valuation parameters, moving from a non-qualifying valuation status to being classified as very expensive. Despite this, the stock has delivered extraordinary returns year-to-date and over the past year, significantly outperforming the Sensex. This article analyses the recent valuation changes, compares them with peer averages, and assesses the implications for investors."
      },
      {
        "title": "iSERA Lifesciences Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/isera-lifesciences-ltd-is-rated-hold-4195172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/iSERALifescienc_mojoScore_4195172.png",
        "date": "2026-09-16 10:10:03",
        "description": "iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 September 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      }
    ],
    "total": 100,
    "sid": "184341",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/isera-lifesciences-184341"
  },
  "announcements": [
    {
      "caption": "Revision In The Corporate Announcement Under Regulation 30 Made On 12/11/2026 Pursuant To The Directions Received From BSE Via Mail",
      "datetime": "14-Nov-2026",
      "details": "Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 - Administrative Warning Letter received from the Securities and Exchange Board of India (the SEBI).",
      "source": "BSE"
    },
    {
      "caption": "Dissemination Of Warning Letter Of SEBI",
      "datetime": "12-Nov-2026",
      "details": "Dissemination of Warning Letter of SEBI",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Nov-2026",
      "details": "Intimation for Newspaper Publication of Un-Audited Financial Results for the quarter and half year ended 30th September 2026 pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "iSERA Lifesciences Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 13",
          "dt": "2013-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "iSERA Lifesciences Ltd has announced <strong>25:1</strong> rights issue, ex-date: 24 Oct 25",
          "dt": "2025-10-24",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Revision In The Corporate Announcement Under Regulation 30 Made On 12/11/2026 Pursuant To The Directions Received From BSE Via Mail

14-Nov-2026 | Source : BSE

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 - Administrative Warning Letter received from the Securities and Exchange Board of India (the SEBI).

Dissemination Of Warning Letter Of SEBI

12-Nov-2026 | Source : BSE

Dissemination of Warning Letter of SEBI

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Nov-2026 | Source : BSE

Intimation for Newspaper Publication of Un-Audited Financial Results for the quarter and half year ended 30th September 2026 pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

iSERA Lifesciences Ltd has declared 5% dividend, ex-date: 20 Sep 13

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

iSERA Lifesciences Ltd has announced 25:1 rights issue, ex-date: 24 Oct 25